eValuation Data

Healthcare & Pharmaceuticals

Calculate specific cost of capital

Specific cost of capital with eValuation Data Plus

Individualize your cost of capital derivation according to the following criteria:
Maturity
Frequency
Cost of capital
Taxes/Country/Currency
Capital structure
Peer group
Request a quote

WACC over the last 12 months

Healthcare & Pharmaceuticals Oct 2023 Nov 2023 Dec 2023 Jan 2024 Feb 2024 Mar 2024 Apr 2024 May 2024 Jun 2024 Jul 2024 Aug 2024 Sep 2024 WACC bandwidth WACC average 8,0% 8,1% 8,2% 7,8% 7,8% 7,8% 7,9% 8,1% 7,9% 8,0% 8,0% 8,0%
eValuation Data Plus

Do you need individual cost of capital?

From 599 EUR plus VAT we support you in deriving your individual cost of capital. Register here!
Discover

WACC summary

Healthcare & Pharmaceuticals, September 2024 Beta 0,9 Market risk premium 6,0% – 8,0% Cost of equity 7,7% – 9,4% Cost of debt 2,5% Risk free rate 2,50% Credit Spread 1,1% Tax Shield 1,1% Risk free rate 2,50% Cost of equity Cost of debt 7,2% – 8,8% WACC 90,6% Equity ratio 9,4% Debt ratio

Trading multiples over the last 12 quarters

Healthcare & Pharmaceuticals Q3 2021 Q4 2021 Q1 2022 Q2 2022 Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 0x 4x 8x 12x 16x 20x 24x EBIT multiple EBITDA multiple

Trendradar

Figure of the month 10.9% – WACC in the technology industry increases to 10.9%!

Daniel Mayr

Question?

Daniel Mayr

Partner
Deal Advisory

Marc Wintermantel

Question?

Marc Wintermantel

Partner
Deal Advisory
German Valuation Leader